• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视神经脊髓炎谱系疾病及相关疾病中的血清神经丝轻链:根据水通道蛋白4和髓鞘少突胶质细胞糖蛋白抗体状态进行的比较

Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status.

作者信息

S Mariotto, A Farinazzo, S Monaco, A Gajofatto, G Zanusso, K Schanda, R Capra, C Mancinelli, A Bonora, R Bombardi, M Reindl, S Ferrari

机构信息

Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Italy.

Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

出版信息

Mult Scler J Exp Transl Clin. 2017 Nov 22;3(4):2055217317743098. doi: 10.1177/2055217317743098. eCollection 2017 Oct-Dec.

DOI:10.1177/2055217317743098
PMID:29204292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5703099/
Abstract

BACKGROUND

Neurofilament light chain (NF-L) levels reflect axonal damage in different conditions, including demyelinating disorders.

OBJECTIVES

We aimed to compare serum NF-L levels in patients with aquaporin-4 antibodies (AQP4-Ab), myelin oligodendrocyte antibodies (MOG-Ab) and seronegative cases with neuromyelitis optica spectrum disorders and related disorders.

METHODS

We analysed AQP4-Ab and MOG-Ab with cell-based assay and NF-L with ultrasensitive electrochemiluminescence immunoassay.

RESULTS

Median NF-L levels were increased in 25 AQP4-Ab-positive patients (59 pg/ml) as compared with 22 MOG-Ab-positive cases (25 pg/ml), 52 seronegative patients (18 pg/ml), 25 multiple sclerosis patients (12 pg/ml) and 14 healthy controls (12 pg/ml).

CONCLUSIONS

Increased serum levels of NF-L in patients with AQP4-Ab or MOG-Ab might reflect an ongoing axonal damage and a more malignant disease course.

摘要

背景

神经丝轻链(NF-L)水平反映了包括脱髓鞘疾病在内的不同情况下的轴突损伤。

目的

我们旨在比较水通道蛋白4抗体(AQP4-Ab)、髓鞘少突胶质细胞糖蛋白抗体(MOG-Ab)阳性患者以及视神经脊髓炎谱系障碍及相关疾病血清学阴性患者的血清NF-L水平。

方法

我们采用基于细胞的检测方法分析AQP4-Ab和MOG-Ab,采用超灵敏电化学发光免疫分析法检测NF-L。

结果

25例AQP4-Ab阳性患者的NF-L水平中位数(59 pg/ml)高于22例MOG-Ab阳性患者(25 pg/ml)、52例血清学阴性患者(18 pg/ml)、25例多发性硬化症患者(12 pg/ml)和14例健康对照者(12 pg/ml)。

结论

AQP4-Ab或MOG-Ab阳性患者血清NF-L水平升高可能反映了持续的轴突损伤和更恶性的病程。

相似文献

1
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status.视神经脊髓炎谱系疾病及相关疾病中的血清神经丝轻链:根据水通道蛋白4和髓鞘少突胶质细胞糖蛋白抗体状态进行的比较
Mult Scler J Exp Transl Clin. 2017 Nov 22;3(4):2055217317743098. doi: 10.1177/2055217317743098. eCollection 2017 Oct-Dec.
2
Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies.血清神经丝轻链和 GFAP 与水通道蛋白 4 或髓鞘少突胶质细胞糖蛋白抗体阳性的炎症性疾病的严重程度相关。
Front Immunol. 2021 Mar 16;12:647618. doi: 10.3389/fimmu.2021.647618. eCollection 2021.
3
Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.视神经脊髓炎谱系疾病伴水通道蛋白 4 和髓鞘少突胶质细胞糖蛋白抗体:一项比较研究。
JAMA Neurol. 2014 Mar;71(3):276-83. doi: 10.1001/jamaneurol.2013.5857.
4
Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.视神经脊髓炎谱系疾病伴髓鞘少突胶质细胞糖蛋白或水通道蛋白-4 抗体:阿尔及利亚患者的临床和辅助检查特征。
J Neurol Sci. 2017 Oct 15;381:240-244. doi: 10.1016/j.jns.2017.08.3254. Epub 2017 Aug 31.
5
The occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative Neuromyelitis Optica Spectrum Disorder: A systematic review and meta-analysis.髓鞘少突胶质细胞糖蛋白抗体在水通道蛋白 4 抗体阴性视神经脊髓炎谱系疾病中的发生:系统评价和荟萃分析。
Mult Scler Relat Disord. 2021 Aug;53:103030. doi: 10.1016/j.msard.2021.103030. Epub 2021 May 28.
6
What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM).AQP4-ab 阴性 NMOSD 患者中 MOG-ab 阳性的比例是多少?一项来自阿根廷多发性硬化症登记处(RelevarEM)的研究。
Mult Scler Relat Disord. 2021 Apr;49:102742. doi: 10.1016/j.msard.2021.102742. Epub 2021 Jan 7.
7
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder.血清生物标志物谱可区分 AQP4 血清阳性和双血清阴性视神经脊髓炎谱系障碍。
Neurol Neuroimmunol Neuroinflamm. 2024 Jan;11(1):e200188. doi: 10.1212/NXI.0000000000200188. Epub 2023 Dec 22.
8
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.视神经脊髓炎及相关疾病中的髓鞘少突胶质细胞糖蛋白免疫球蛋白G:50例患者的多中心研究。第1部分:频率、综合征特异性、疾病活动的影响、长期病程、与水通道蛋白4免疫球蛋白G的关联及起源
J Neuroinflammation. 2016 Sep 26;13(1):279. doi: 10.1186/s12974-016-0717-1.
9
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.血清 GFAP 和 NfL 作为水通道蛋白-4 抗体阳性视神经脊髓炎谱系疾病的疾病严重程度和预后生物标志物。
J Neuroinflammation. 2021 May 1;18(1):105. doi: 10.1186/s12974-021-02138-7.
10
Relationship between blood-brain permeability and antibodies against aquaporins in neuromyelitis optica spectrum disorders and multiple sclerosis patients.视神经脊髓炎谱系疾病和多发性硬化患者血脑屏障通透性与水通道蛋白抗体的关系。
Neurol Neurochir Pol. 2022;56(4):308-317. doi: 10.5603/PJNNS.a2022.0007. Epub 2022 Jan 14.

引用本文的文献

1
Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder.脑脊液中14-3-3蛋白水平作为水通道蛋白4抗体阳性视神经脊髓炎谱系障碍的神经轴突生物标志物
Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200432. doi: 10.1212/NXI.0000000000200432. Epub 2025 Jun 30.
2
Extracellular Vesicle Marker Changes Associated With Disease Activity in Relapsing-Remitting Multiple Sclerosis.复发缓解型多发性硬化症中与疾病活动相关的细胞外囊泡标志物变化
Neurol Neuroimmunol Neuroinflamm. 2025 Jul;12(4):e200404. doi: 10.1212/NXI.0000000000200404. Epub 2025 Apr 29.
3
A roadmap to increasing access to AQP4-Ig testing for NMOSD: expert recommendations.改善视神经脊髓炎谱系障碍(NMOSD)患者获取水通道蛋白4抗体(AQP4-Ig)检测的途径路线图:专家建议
Arq Neuropsiquiatr. 2025 Feb;83(2):1-11. doi: 10.1055/s-0045-1801845. Epub 2025 Mar 19.
4
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies.血清星形胶质细胞和神经元标志物与水通道蛋白4及髓鞘少突胶质细胞糖蛋白自身抗体之间的关系。
Clin Proteomics. 2024 Apr 5;21(1):28. doi: 10.1186/s12014-024-09466-9.
5
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies.血清星形胶质细胞和神经元标志物与水通道蛋白4及髓鞘少突胶质细胞糖蛋白自身抗体之间的关系。
Res Sq. 2023 Nov 29:rs.3.rs-3659922. doi: 10.21203/rs.3.rs-3659922/v1.
6
Serum proteins for monitoring and predicting visual function in patients with recent optic neuritis.用于监测和预测近期视神经炎患者视觉功能的血清蛋白。
Sci Rep. 2023 Apr 5;13(1):5609. doi: 10.1038/s41598-023-32748-5.
7
Early blood neurofilament light chain and myelin oligodendrocyte glycoprotein antibody levels associate with different disease courses of myelin oligodendrocyte glycoprotein-associated disease in children.早期血神经丝轻链和髓鞘少突胶质细胞糖蛋白抗体水平与儿童髓鞘少突胶质细胞糖蛋白相关疾病的不同病程相关。
Brain Commun. 2023 Mar 15;5(2):fcad063. doi: 10.1093/braincomms/fcad063. eCollection 2023.
8
Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease.视神经脊髓炎谱系障碍和髓鞘少突胶质细胞糖蛋白相关疾病中的血清和脑脊液生物标志物
Front Neurol. 2022 Mar 23;13:866824. doi: 10.3389/fneur.2022.866824. eCollection 2022.
9
A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies.视神经炎恢复模式的纵向比较:针对髓鞘少突胶质细胞糖蛋白(MOG)抗体血清阳性以及水通道蛋白4(AQP4)抗体血清阳性或双抗体血清阴性的情况
J Ophthalmol. 2022 Mar 22;2022:4951491. doi: 10.1155/2022/4951491. eCollection 2022.
10
Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes.小儿获得性脱髓鞘综合征中的血清神经丝轻链水平和髓鞘少突胶质细胞糖蛋白抗体
Front Neurol. 2021 Nov 11;12:754518. doi: 10.3389/fneur.2021.754518. eCollection 2021.

本文引用的文献

1
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.血清神经丝轻链:多发性硬化症中神经元损伤的生物标志物。
Ann Neurol. 2017 Jun;81(6):857-870. doi: 10.1002/ana.24954.
2
Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis.脑脊液中的神经丝轻链与临床孤立综合征及复发缓解型多发性硬化症疾病活动的预测
Eur J Neurol. 2017 May;24(5):703-712. doi: 10.1111/ene.13274. Epub 2017 Mar 6.
3
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.伴有髓鞘少突胶质细胞糖蛋白(MOG)抗体的神经炎性疾病中无星形细胞病变的髓鞘损伤
J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1257-1259. doi: 10.1136/jnnp-2015-312676. Epub 2016 Jan 22.
4
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.视神经脊髓炎谱系障碍国际共识诊断标准
Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.
5
Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.视神经脊髓炎中的脑脊液轻神经丝和重神经丝。
Neurochem Int. 2013 Dec;63(8):805-8. doi: 10.1016/j.neuint.2013.10.008. Epub 2013 Oct 23.
6
Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.神经丝轻链血液水平在神经退行性神经疾病中的升高。
PLoS One. 2013 Sep 20;8(9):e75091. doi: 10.1371/journal.pone.0075091. eCollection 2013.
7
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.视神经脊髓炎和相关疾病中髓鞘少突胶质细胞糖蛋白的补体激活抗体。
J Neuroinflammation. 2011 Dec 28;8:184. doi: 10.1186/1742-2094-8-184.
8
Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.中枢神经系统脱髓鞘疾病中抗 MO-G 抗体的时间动态变化。
Clin Immunol. 2011 Mar;138(3):247-54. doi: 10.1016/j.clim.2010.11.013. Epub 2010 Dec 18.
9
Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.在 NMO 中,星形胶质细胞损伤远比脱髓鞘严重:一项临床 CSF 生物标志物研究。
Neurology. 2010 Jul 20;75(3):208-16. doi: 10.1212/WNL.0b013e3181e2414b.